Literature DB >> 24776754

Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome.

Lenneke Schrier1, Marieke L de Kam, Rachel McKinnon, Amalina Che Bakri, Wilma Oostdijk, Theo C J Sas, Leonie A Menke, Barto J Otten, Sabine M P F de Muinck Keizer-Schrama, Berit Kristrom, Carina Ankarberg-Lindgren, Jacobus Burggraaf, Kerstin Albertsson-Wikland, Jan M Wit.   

Abstract

BACKGROUND/AIMS: Growth Hormone (GH) dosage in childhood is adjusted for body size, but there is no consensus whether body weight (BW) or body surface area (BSA) should be used. We aimed at comparing the biological effect and cost-effectiveness of GH treatment dosed per m2 BSA in comparison with dosing per kg BW in girls with Turner syndrome (TS).
METHODS: Serum IGF-I, GH dose, and adult height gain (AHG) from girls participating in two Dutch and five Swedish studies on the efficacy of GH were analyzed, and the cumulative GH dose and costs were calculated for both dose adjustment methods. Additional medication included estrogens (if no spontaneous puberty occurred) and oxandrolone in some studies.
RESULTS: At each GH dose, the serum IGF-I standard deviation score remained stable over time after an initial increase after the start of treatment. On a high dose (at 1 m2 equivalent to 0.056-0.067 mg/kg/day), AHG was at least equal on GH dosed per m2 BSA compared with dosing per kg BW. The cumulative dose and cost were significantly lower if the GH dose was adjusted for m2 BSA.
CONCLUSION: Dosing GH per m2 BSA is at least as efficacious as dosing per kg BW, and is more cost-effective.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24776754     DOI: 10.1159/000357844

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  5 in total

Review 1.  Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.

Authors:  Paulo F Collett-Solberg; Geoffrey Ambler; Philippe F Backeljauw; Martin Bidlingmaier; Beverly M K Biller; Margaret C S Boguszewski; Pik To Cheung; Catherine Seut Yhoke Choong; Laurie E Cohen; Pinchas Cohen; Andrew Dauber; Cheri L Deal; Chunxiu Gong; Yukihiro Hasegawa; Andrew R Hoffman; Paul L Hofman; Reiko Horikawa; Alexander A L Jorge; Anders Juul; Peter Kamenický; Vaman Khadilkar; John J Kopchick; Berit Kriström; Maria de Lurdes A Lopes; Xiaoping Luo; Bradley S Miller; Madhusmita Misra; Irene Netchine; Sally Radovick; Michael B Ranke; Alan D Rogol; Ron G Rosenfeld; Paul Saenger; Jan M Wit; Joachim Woelfle
Journal:  Horm Res Paediatr       Date:  2019-09-12       Impact factor: 2.852

2.  Turner syndrome and associated problems in Turkish children: a multicenter study.

Authors:  Ediz Yeşilkaya; Abdullah Bereket; Feyza Darendeliler; Firdevs Baş; Şükran Poyrazoğlu; Banu Küçükemre Aydın; Şükran Darcan; Bumin Dündar; Muammer Büyükinan; Cengiz Kara; Erkan Sarı; Erdal Adal; Ayşehan Akıncı; Mehmet Emre Atabek; Fatma Demirel; Nurullah Çelik; Behzat Özkan; Bayram Özhan; Zerrin Orbak; Betül Ersoy; Murat Doğan; Ali Ataş; Serap Turan; Damla Gökşen; Ömer Tarım; Bilgin Yüksel; Oya Ercan; Şükrü Hatun; Enver Şimşek; Ayşenur Ökten; Ayhan Abacı; Hakan Döneray; Mehmet Nuri Özbek; Mehmet Keskin; Hasan Önal; Nesibe Akyürek; Kezban Bulan; Derya Tepe; Hamdi Cihan Emeksiz; Korcan Demir; Deniz Kızılay; Ali Kemal Topaloğlu; Erdal Eren; Samim Özen; Saygın Abalı; Leyla Akın; Beray Selver Eklioğlu; Sultan Kaba; Ahmet Anık; Serpil Baş; Tolga Ünüvar; Halil Sağlam; Semih Bolu; Tolga Özgen; Durmuş Doğan; Esra Deniz Çakır; Yaşar Şen; Nesibe Andıran; Filiz Çizmecioğlu; Olcay Evliyaoğlu; Gülay Karagüzel; Özgür Pirgon; Gönül Çatlı; Hatice Dilek Can; Fatih Gürbüz; Çiğdem Binay; Veysel Nijat Baş; Kürşat Fidancı; Adem Polat; Davut Gül; Cengizhan Açıkel; Hüseyin Demirbilek; Peyami Cinaz; Carolyn Bondy
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

Review 3.  Diagnostic and therapeutic considerations in Turner syndrome.

Authors:  Seung Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

4.  Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height.

Authors:  Daniel B Hawcutt; Jennifer Bellis; Victoria Price; Anne Povall; Paul Newland; Paul Richardson; Matthew Peak; Jo Blair
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

Review 5.  Weight-based dosing in medication use: what should we know?

Authors:  Sheng-Dong Pan; Ling-Ling Zhu; Meng Chen; Ping Xia; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2016-04-12       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.